PHVS
Pharvaris N.v.
Late-stage biopharmaceutical company developing oral bradykinin B2 receptor antagonists
CUSIP: N69605108HealthcareCH1 holder
Total Value
$101.38M
Total Shares
3.65M
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
Viking Global Investors
$101.38M3.65M sharesUnchanged